Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Conserved HBV and HCV sequences useful for gene silencing

Conserved HBV and HCV sequences useful for gene silencing

US Patent 9200281 · Granted Dec 1, 2015

Estimated economic value: $21,877,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Conserved HBV and HCV sequences useful for gene silencing2021
Conserved HBV and HCV sequences useful for gene silencing2021
Conserved HBV and HCV sequences useful for gene silencing2021
Conserved HBV and HCV sequences useful for gene silencing2021
Ghrelin splice variant for treating neuronal damage, neurodegenerative disease, 2020
Conserved HBV and HCV sequences useful for gene silencing2018
Conserved HBV and HCV sequences useful for gene silencing2018
Conserved HBV and HCV sequences useful for gene silencing2018
Conserved HBV and HCV sequences useful for gene silencing2018
Targeting opposite strand replication intermediates of single-stranded viruses b2015
Post-transcriptional gene silencing using expressed double stranded RNA2015
Post-transcriptional gene silencing using expressed double stranded RNA2015